Abiopharma

🔍 Curran Mary A (Executive)

Company: BANC OF CALIFORNIA, INC. (BANC)

Report Date: 2026-05-06

Detailed Transactions and Holdings:

• Acquired 4,780 shares of Common Stock (Direct)
  Date: 2026-05-06 | Code: A | equity_swap_involved: false | shares_owned_after: 10,663.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-06 | Code: H | nature_of_ownership: By the Mary Allis Curran Trust | shares_owned_after: 60,456.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-06 | Code: H | nature_of_ownership: Mary A. Curran IRA Rollover | shares_owned_after: 5,555.00 | Footnotes: F3

Footnotes:

• F1: Represents restricted stock units ("RSUs") issued to the Reporting Person as consideration for her service on the Issuer's Board of Directors. Shares will be issued in full upon vesting, which is scheduled to occur on the one-year anniversary of the grant date.
• F2: Amount reported includes 5,366 shares transferred by the Reporting Person into the Mary Allis Curran Trust previously reported as directly held. Amount reported also includes 1,375 shares of the Issuer's common stock acquired pursuant to a broker-administered dividend reinvestment plan.
• F3: Amount reported includes 139 shares of the Issuer's common stock acquired pursuant to a broker-administered dividend reinvestment plan.